An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines.
作者信息
Schiffman Mark, Wentzensen Nicolas, Perkins Rebecca B, Guido Richard S
机构信息
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD.
Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA.
出版信息
J Low Genit Tract Dis. 2020 Apr;24(2):87-89. doi: 10.1097/LGT.0000000000000531.
Abstract
摘要
相似文献
1
An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines.2019年美国阴道镜和子宫颈病理学会基于风险的管理共识指南介绍
J Low Genit Tract Dis. 2020 Apr;24(2):87-89. doi: 10.1097/LGT.0000000000000531.
2
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.2019年美国阴道镜和子宫颈病理学会基于风险的子宫颈癌筛查异常检测及癌前病变管理共识指南。
J Low Genit Tract Dis. 2020 Apr;24(2):102-131. doi: 10.1097/LGT.0000000000000525.
3
The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.临床医生的观点：人乳头瘤病毒检测在美国阴道镜及宫颈病理学会异常宫颈细胞学和宫颈癌前病变管理指南中的作用
Arch Pathol Lab Med. 2003 Aug;127(8):950-8. doi: 10.5858/2003-127-950-TCVROH.
4
Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.支持 2019 ASCCP 基于风险的管理共识指南的风险估计。
J Low Genit Tract Dis. 2020 Apr;24(2):132-143. doi: 10.1097/LGT.0000000000000529.
5
ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.美国临床肿瘤学会/美国阴道镜及子宫颈病理学会/美国临床病理学会子宫颈癌早期检测指南
Am Fam Physician. 2012 Sep 15;86(6):501, 506-7.
6
Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines.为新一轮美国阴道镜和子宫颈病理学会（ASCCP）主办的子宫颈癌筛查与管理指南做准备。
J Low Genit Tract Dis. 2017 Apr;21(2):87-90. doi: 10.1097/LGT.0000000000000300.
7
2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation.2019 ASCCP 基于风险的管理共识指南：风险评估方法、推荐管理及验证。
J Low Genit Tract Dis. 2020 Apr;24(2):90-101. doi: 10.1097/LGT.0000000000000528.
8
Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.对致编辑信的回复：关于《2019年美国阴道镜和子宫颈病理学会基于风险的子宫颈癌筛查异常检测及癌前病变管理共识指南》
J Low Genit Tract Dis. 2020 Oct;24(4):426. doi: 10.1097/LGT.0000000000000562.
9
Trial quickly changed management of cervical abnormalities.该试验迅速改变了宫颈异常的管理方式。
J Natl Cancer Inst. 2005 Apr 6;97(7):479-80. doi: 10.1093/jnci/97.7.479.
10
Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005.2000 - 2005年国家乳腺癌和宫颈癌早期检测项目中低度细胞学异常的随访评估。
J Low Genit Tract Dis. 2008 Oct;12(4):300-6. doi: 10.1097/LGT.0b013e31817e308e.
引用本文的文献
1
Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control.回顾过去，展望未来：全球宫颈癌预防与控制的挑战与机遇。
Viruses. 2024 Aug 25;16(9):1357. doi: 10.3390/v16091357.
2
The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma.HPV 16、18 或 45 与细胞学非典型腺细胞（AGC）的联合发现表明原位和浸润性宫颈腺癌的风险大大增加。
Gynecol Oncol. 2023 Jul;174:253-261. doi: 10.1016/j.ygyno.2023.05.011. Epub 2023 May 25.
3
p16 flow cytometry of exfoliated cervical cells: Its role in quantitative pathology and clinical diagnosis of squamous intraepithelial lesions.巴氏涂片宫颈细胞的 p16 流式细胞术：在鳞状上皮内病变的定量病理学和临床诊断中的作用。
Clin Transl Med. 2023 Mar;13(3):e1209. doi: 10.1002/ctm2.1209.
4
Altered vaginal eukaryotic virome is associated with different cervical disease status.阴道真核病毒组的改变与不同的宫颈疾病状态有关。
Virol Sin. 2023 Apr;38(2):184-197. doi: 10.1016/j.virs.2022.12.004. Epub 2022 Dec 21.
5
Risk-Based Colposcopy for Cervical Precancer Detection: A Cross-Sectional Multicenter Study in China.基于风险的阴道镜检查用于宫颈癌前病变检测：一项在中国开展的横断面多中心研究
Diagnostics (Basel). 2022 Oct 25;12(11):2585. doi: 10.3390/diagnostics12112585.
6
Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesion cytology, and its immediate risk for high-grade cervical lesion or cancer: a single-center, cross-sectional study.低级别鳞状上皮内病变细胞学中人乳头瘤病毒基因型分布及其发展为高级别宫颈病变或癌症的直接风险：一项单中心横断面研究
Obstet Gynecol Sci. 2022 Jul;65(4):335-345. doi: 10.5468/ogs.22025. Epub 2022 Apr 21.
7
Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program.采用高通量 COR 仪器对 Onclarity 检测进行方法迁移后，对丹麦宫颈癌筛查项目中的 SurePath 筛查样本进行临床验证。
Am J Clin Pathol. 2022 Mar 3;157(3):390-398. doi: 10.1093/ajcp/aqab138.
8
Should the management of high grade cervical squamous intraepithelial lesion (HSIL) be different in HIV-positive women?高级别宫颈鳞状上皮内病变（HSIL）的管理是否应在 HIV 阳性女性中有所不同？
AIDS Res Ther. 2021 Jul 23;18(1):44. doi: 10.1186/s12981-021-00371-x.
9
Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16 immunostaining in China.在中国，采用 HPV 基因分型和 p16 免疫组化检测对 HPV 阳性、细胞学阴性的宫颈癌筛查结果进行分流。
BMC Infect Dis. 2021 Apr 30;21(1):400. doi: 10.1186/s12879-021-06109-4.
10
Colposcopic Impression Has a Key Role in the Estimation of the Risk of HSIL/CIN3.阴道镜印象在评估高级别鳞状上皮内病变/宫颈上皮内瘤变3级的风险中起关键作用。
Cancers (Basel). 2021 Mar 11;13(6):1224. doi: 10.3390/cancers13061224.
本文引用的文献
1
Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests.将利益相关者的反馈纳入异常宫颈癌筛查检测管理指南的制定中。
J Low Genit Tract Dis. 2020 Apr;24(2):167-177. doi: 10.1097/LGT.0000000000000524.
2
Reporting and Assessing the Quality of Diagnostic Accuracy Studies for Cervical Cancer Screening and Management.报告和评估宫颈癌筛查和管理的诊断准确性研究的质量。
J Low Genit Tract Dis. 2020 Apr;24(2):157-166. doi: 10.1097/LGT.0000000000000527.
3
A Systematic Review of Tests for Postcolposcopy and Posttreatment Surveillance.阴道镜检查后和治疗后监测的检测方法的系统评价
J Low Genit Tract Dis. 2020 Apr;24(2):148-156. doi: 10.1097/LGT.0000000000000526.
4
A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines.支持 2019 年 ASCCP 基于风险的管理共识指南的部分人乳头瘤病毒基因分型研究。
J Low Genit Tract Dis. 2020 Apr;24(2):144-147. doi: 10.1097/LGT.0000000000000530.
5
Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.支持 2019 ASCCP 基于风险的管理共识指南的风险估计。
J Low Genit Tract Dis. 2020 Apr;24(2):132-143. doi: 10.1097/LGT.0000000000000529.
6
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.2019年美国阴道镜和子宫颈病理学会基于风险的子宫颈癌筛查异常检测及癌前病变管理共识指南。
J Low Genit Tract Dis. 2020 Apr;24(2):102-131. doi: 10.1097/LGT.0000000000000525.
7
2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation.2019 ASCCP 基于风险的管理共识指南：风险评估方法、推荐管理及验证。
J Low Genit Tract Dis. 2020 Apr;24(2):90-101. doi: 10.1097/LGT.0000000000000528.
8
Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines.为新一轮美国阴道镜和子宫颈病理学会（ASCCP）主办的子宫颈癌筛查与管理指南做准备。
J Low Genit Tract Dis. 2017 Apr;21(2):87-90. doi: 10.1097/LGT.0000000000000300.
9
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.2012 年更新的异常宫颈癌筛查试验和癌前病变管理共识指南。
J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S1-S27. doi: 10.1097/LGT.0b013e318287d329.
10
2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.2006年宫颈上皮内瘤变或原位腺癌女性管理共识指南
J Low Genit Tract Dis. 2007 Oct;11(4):223-39. doi: 10.1097/LGT.0b013e318159408b.
Zotero 插件